01.10.2012 • News • Sanofi • appointments • People

Sanofi Appoints Dr. Paul Chew Chief Medical Officer

Sanofi is pleased to announce today the appointment of Dr. Paul Chew, Senior Vice President, Chief Medical Officer and Head of Global Medical Affairs as of January 1, 2013.

Dr. Chew, currently Senior Vice President, Chief Science Officer and Chief Medical Officer at Sanofi, U.S., will succeed Jean-Pierre Lehner, who will retire on December 31, 2012, after more than 20 years of dedicated service to the company.

Dr. Chew will report to Dr. Elias Zerhouni, President, Global Research & Development and will be based in Bridgewater, NJ and Paris, France.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Top-Feature

most read